The purpose of this study is to see if a combined pill of Angiotensin-converting enzyme (ACE) inhibitors (a medication that helps relax your veins and arteries to lower your blood pressure) with diuretics (sometimes called water pills, help rid your body of salt and water) will control blood pressure better than a different blood pressure medication of calcium channel blocker (lower your blood pressure by preventing calcium from entering the cells of your heart and arteries). Both medications are part of our usual care for high blood pressure after delivery.
In individuals with preeclampsia, persistent hypertension and edema result in part from the mobilization of up to 8 liters of fluid and sodium from the extravascular to intravascular space. The increased urinary sodium excretion on days 3-5 postpartum likely results from higher atrial natriuretic peptide concentrations in plasma and activation of the renin-angiotensin-aldosterone system. Adding diuretics for postpartum hypertension has been associated with better blood pressure control in some of the studies. * CVD is the leading cause for mortality worldwide. * Primary prevention is more effective than treating CVD. * Pregnancy is often the 1st adult engagement with the healthcare system. * Preeclampsia is a risk factor for long term CVD, even after controlling for mutual risk factors. * CVD is the leading cause for pregnancy related mortality. * There is no good data regarding the optimal medications to control blood pressure after delivery. * ACE inhibitors play an important role in controlling blood pressure outside of pregnancy and there is extensive evidence to support their cardioprotective effects. * The optimal use of diuretics in the postpartum in patients with preeclampsia, require further study and clarification to augment current management schemes. Hypothesis: that in postpartum women with hypertensive disorders, oral combined Hydrochlorothiazide/Lisinopril will reduce postpartum hypertension at 7 days after delivery compared to usual care with calcium channel blockers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
70
Hctz/Lisinopril (brand name: Zestoretic)
Extended release nifedipine
University of Texas Health Science Center
Houston, Texas, United States
Number of Participants With Stage 2 Hypertension
Stage 2 hypertension at day 7-10 after delivery (defined as SBP ≥ 140 and/or DBP ≥ 90 mmHg) or admission to the hospital for blood pressure control prior to day 10. Primary outcome will be calculated as the average BP reading for day 7-10 after delivery.
Time frame: 7-10 after delivery
Number of Participants With Severe Postpartum Hypertension
severe postpartum hypertension (SBP≥160 and/or DBP≥110 mmHg on 2 occasions, 15 minutes apart)
Time frame: 7-10 after delivery
Number of Participants Who Received Additional Antihypertensive During Admission
number of participants who received additional antihypertensive during admission, at 7-10 days postpartum.
Time frame: 7-10 days postpartum
Postpartum Length of Stay
time spent in hospital following delivery
Time frame: up to 30 days after delivery
Postpartum Readmission
occurrence of returning to hospital for admission postpartum
Time frame: up to 30 days after delivery
Time to Blood Pressure Control
The time from delivery to Blood Pressure control (i.e time from delivery to last BP \<150/100).
Time frame: 10 days
Incidence of Persistent Postpartum Hypertension
Incidence of persistent postpartum hypertension 6 weeks postpartum (SBP ≥ 140 and/or DBP ≥ 90 mmHg).
Time frame: 6 weeks postpartum
Occurrence of Proteinuria
Proteinuria is measured by urine protein creatinine ratio
Time frame: 7-10 days, and 6 weeks postpartum
Presense of Labs Abnormality
Labs abnormality including hyperkalemia or creatinine increase
Time frame: 7-10 days, and 6 weeks postpartum
Compliance With Medications
Compliance with medications. The patient will be asked to bring their medication bottle with them and the compliance will be measured by counting pills at each postpartum visit.
Time frame: at the time of the 1st postpartum clinic visit, which is about 6 to 37 days after birth
Time to Control Blood Pressure
Blood pressure at 3 month, 6 month, 9 month, 1 year after delivery and need for BP medications. Definition of controlled blood pressure is (SBP \< 140 and/or DBP \< 90 mmHg). This will be assessed by telephone encounter with the patient
Time frame: 3 month-1 year
Number of Patients Receiving Primary Care With BP Measurement
Number of patients receiving primary care with BP measurement at 1 year
Time frame: 1 year postpartum
Postpartum Complications- Number of Participants With ICU Admission
Need for ICU admission
Time frame: 10 days postpartum
Postpartum Complications- Number of Participants With HELLP (Hemolysis, Elevated Liver Enzymes and Low Platelets) Syndrome
Hemolysis, elevated liver enzymes, low platelet count: HELLP
Time frame: 10 days postpartum
Postpartum Complications- Number of Participants With Eclampsia
Eclampsia, which is considered a complication of severe preeclampsia, is commonly defined as new onset of grand mal seizure activity and/or unexplained coma during pregnancy or postpartum in a woman with signs or symptoms of preeclampsia.
Time frame: 10 days postpartum
Postpartum Complications- Number of Participants With Stroke
Stroke
Time frame: 10 days postpartum
Postpartum Complications- Number of Participants With Renal Failure
Renal failure
Time frame: 10 days postpartum
Postpartum Complications- Number of Participants With Pulmonary Edema
Pulmonary edema
Time frame: 10 days postpartum
Postpartum Complications - Number of Participants With Cardiomyopathy
Cardiomyopathy
Time frame: 10 days postpartum
Postpartum Complications- Number of Participants With Maternal Death
Maternal death
Time frame: 10 days postpartum
Receipt of Additional Antihypertensive During Admission
Receipt of additional antihypertensive during admission at 6 weeks postpartum
Time frame: 6 weeks postpartum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.